Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...

Recent research challenges the notion that back sleeping is beneficial. It can worsen sleep apnea, acid reflux, and even ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

Doctor Ian Newberrry with RI ENT and Brown University Health was instrumental in bringing it here to RI in 2024.

Sleepwalking, affecting millions, involves being stuck between sleep and wakefulness, often during deep non-REM sleep.

Apnimed, a startup in Cambridge, this month reported positive test results for a pill - form medication to treat sleep apnea. If approved by federal regulators, it would become the first pill to treat ...

As we approach the first day of school, parents and caregivers should be thinking of ways to get their students back into ...

Resmed CEO Mick Farrell addressed the latest potential threats to the CPAP therapy market during a recent webcast: The ...

The factors that raise the risk of heart disease and stroke can also raise the risk of dementia. When blood vessels are ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $289.62, a high estimate of $325 ...